See more : Giglio Group S.p.A. (GG.MI) Income Statement Analysis – Financial Results
Complete financial analysis of Empower Clinics Inc. (EPWCF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Empower Clinics Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Guangdong Greenway Technology Co., Ltd. (688345.SS) Income Statement Analysis – Financial Results
- Montrose Environmental Group, Inc. (MEG) Income Statement Analysis – Financial Results
- G3 VRM Acquisition Corp. (GGGVR) Income Statement Analysis – Financial Results
- Gencor Industries, Inc. (GENC) Income Statement Analysis – Financial Results
- ReneSola Ltd (SOL) Income Statement Analysis – Financial Results
Empower Clinics Inc. (EPWCF)
About Empower Clinics Inc.
Empower Clinics Inc., an integrated healthcare company, provides body and mind wellness services for patients through digital and telemedicine care, and medical diagnostics laboratories in the United States and Canada. The company operates a pipeline of 33 clinics in Alberta, British Columbia, and New Brunswick. It has a strategic alliance with SoLVBL Solutions Inc. to develop a program for data security in diagnostic testing. Empower Clinics Inc. is based in Vancouver, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.66M | 4.37M | 3.21M | 2.03M | 1.09M | 1.56M | 2.13K | 0.00 | 17.00K | 17.00K | 1.89M | 1.32M | 912.60K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 2.69M | 3.02M | 1.19M | 826.28K | 417.05K | 768.90K | 718.11 | 0.00 | 0.00 | 8.64M | 12.25M | 4.76M | 1.35M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 1.97M | 1.35M | 2.02M | 1.21M | 674.34K | 792.35K | 1.42K | 0.00 | 17.00K | -8.62M | -10.36M | -3.44M | -434.05K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 42.22% | 30.87% | 62.81% | 59.33% | 61.79% | 50.75% | 66.36% | 0.00% | 100.00% | -50,729.41% | -548.54% | -259.71% | -47.56% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 962.73K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.20M | 4.60M | 3.74M | 3.80M | 4.50M | 113.00K | 268.00K | 349.00K | 93.00K | 2.29M | 2.31M | 4.89M | 1.97M | 1.37M | 247.64K | 90.64K | 68.05K | 17.45K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 652.13K | 751.51K | 1.03M | 313.87K | 306.80K | 171.81 | 60.35 | 0.00 | 0.00 | 0.00 | 0.00 | 401.00K | 0.00 | 4.57K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 6.75M | 5.35M | 4.77M | 4.12M | 4.81M | 113.00K | 268.00K | 349.00K | 93.00K | 2.29M | 2.31M | 5.29M | 1.97M | 1.38M | 247.64K | 90.64K | 68.05K | 17.45K | 34.47K | 73.49K | 140.33K | 178.59K | 264.37K | 43.79K |
| Other Expenses | 173.07K | 1.41M | 850.85K | 604.31K | 829.43K | 0.00 | 0.00 | 23.02K | 469.00K | 765.00K | 3.52M | 4.84M | 1.22K | 5.88K | 37.54K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 730.76K | 856.23K | 64.85K |
| Operating Expenses | 6.92M | 6.75M | 5.62M | 4.72M | 4.98M | 113.00K | 268.00K | 349.00K | 562.00K | 3.06M | 5.83M | 5.29M | 2.94M | 1.38M | 285.18K | 90.64K | 68.05K | 17.45K | 34.47K | 73.49K | 140.33K | 909.34K | 1.12M | 108.63K |
| Cost & Expenses | 9.62M | 9.78M | 6.81M | 5.55M | 5.40M | 113.00K | 268.00K | 349.00K | 562.00K | 3.06M | 5.83M | 10.05M | 2.94M | 1.38M | 285.18K | 90.64K | 68.05K | 17.45K | 34.47K | 73.49K | 140.33K | 909.34K | 1.12M | 108.63K |
| Interest Income | 911.23K | 185.41K | 7.57K | 4.98K | 0.00 | 6.00K | 0.00 | 0.00 | 0.00 | 3.03M | 2.48M | 43.00K | 398.00 | 0.00 | 40.06K | 0.00 | 31.87K | 360.00 | 0.00 | 1.29K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.55M | 185.41K | 539.41K | 355.05K | 367.90K | 0.00 | 0.00 | 0.00 | 0.00 | 30.00K | 745.00K | 109.00K | 0.00 | 0.00 | -285.18K | -90.64K | -35.40K | -18.75K | -64.09K | -341.81K | -137.40K | -893.77K | -1.11M | -108.63K |
| Depreciation & Amortization | 205.04K | 535.12K | 188.38K | 334.66K | 117.18K | 107.09K | 106.17K | 55.00K | 45.00K | 88.00K | 96.00K | 80.00K | 1.22K | 14.71K | 2.52K | 65.31K | 1.23K | 415.00 | 565.00 | 772.00 | 1.06K | 1.44K | 410.00 | 11.47K |
| EBITDA | -1.09M | -30.74M | -16.84M | -3.70M | -3.13M | -2.23M | -212.41K | -247.76K | 743.78K | -5.39M | -4.35M | -9.66M | -2.02M | -1.50M | -268.33K | 0.00 | -36.17K | -19.35K | -66.53K | -72.72K | -138.34K | -907.91K | -1.12M | -108.63K |
| EBITDA Ratio | -23.35% | -105.37% | -100.14% | -140.57% | -307.54% | -9.67% | -15,036.14% | 0.00% | -10,670.59% | 447.06% | -72.42% | -650.26% | -222.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -4.95M | -5.41M | -3.61M | -3.52M | -4.31M | -113.00K | -268.00K | -349.00K | 772.00K | -8.64M | -12.25M | -9.95M | -2.03M | -1.38M | -285.18K | -90.64K | -68.05K | -17.45K | -34.47K | -73.49K | -140.33K | -893.77K | -1.11M | -108.63K |
| Operating Income Ratio | -106.28% | -123.75% | -112.35% | -173.02% | -394.85% | -7.24% | -12,553.53% | 0.00% | 4,541.18% | -50,829.41% | -648.54% | -752.23% | -222.14% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 2.11M | -26.29M | -13.09M | -163.45K | 519.46K | -3.11M | -1.00K | 49.74K | 1.27M | -2.27M | -6.06M | -66.00K | 398.00 | 14.71K | 2.52K | 65.31K | 31.87K | -1.33K | -29.62K | -268.32K | 2.93K | 0.00 | 0.00 | 11.47K |
| Income Before Tax | -2.84M | -31.74M | -17.07M | -4.30M | -3.79M | -75.00K | -215.00K | -269.00K | 735.00K | -5.64M | -10.52M | -10.02M | -2.03M | -1.37M | -282.66K | -25.33K | -36.17K | -18.77K | -64.09K | -341.81K | -137.40K | -893.77K | -1.11M | -97.17K |
| Income Before Tax Ratio | -61.00% | -726.41% | -531.79% | -211.74% | -347.26% | -4.80% | -10,070.93% | 0.00% | 4,323.53% | -33,200.00% | -556.70% | -757.22% | -222.10% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 165.00 | 968.67K | 542.21K | 812.18K | -519.46K | -38.00K | -53.00K | -55.00K | 37.00K | 2.61M | 41.00K | 33.00K | 6.22K | 1.37M | 282.66K | 25.33K | 36.17K | 18.77K | 64.09K | 341.81K | 137.40K | 893.77K | 1.11M | 97.17K |
| Net Income | -2.83K | -32.70M | -17.61M | -5.11M | -3.79M | -75.00K | -215.00K | -269.00K | 735.00K | -5.64M | -8.55M | -10.05M | -2.03M | -1.37M | -282.66K | -25.33K | -36.17K | -18.77K | -64.09K | -341.81K | -137.40K | -893.77K | -1.11M | -97.17K |
| Net Income Ratio | -0.06% | -748.58% | -548.69% | -251.72% | -347.26% | -4.80% | -10,070.93% | 0.00% | 4,323.53% | -33,200.00% | -452.83% | -759.71% | -222.78% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.04 | -0.50 | -0.48 | -0.22 | -0.28 | -0.02 | -0.06 | -0.09 | 0.30 | -2.34 | -4.83 | -7.55 | -2.43 | -3.89 | -0.91 | -0.08 | -0.13 | -0.08 | -0.29 | -1.44 | -0.53 | -3.75 | -5.25 | -0.75 |
| EPS Diluted | -0.04 | -0.50 | -0.48 | -0.22 | -0.28 | -0.02 | -0.06 | -0.09 | 0.30 | -2.34 | -4.83 | -7.55 | -2.43 | -3.89 | -0.91 | -0.08 | -0.13 | -0.08 | -0.29 | -1.44 | -0.53 | -3.75 | -5.25 | -0.75 |
| Weighted Avg Shares Out | 70.21M | 65.60M | 36.47M | 23.46M | 13.33M | 3.42M | 3.42M | 3.09M | 2.43M | 2.41M | 1.77M | 1.33M | 835.20K | 352.20K | 309.33K | 309.33K | 268.96K | 221.33K | 221.33K | 237.88K | 261.33K | 238.34K | 210.76K | 129.55K |
| Weighted Avg Shares Out (Dil) | 70.21M | 65.60M | 36.47M | 23.46M | 13.33M | 3.42M | 3.42M | 3.09M | 2.43M | 2.41M | 1.77M | 1.33M | 835.20K | 352.20K | 309.33K | 309.33K | 268.96K | 221.33K | 221.33K | 237.88K | 261.33K | 238.34K | 210.76K | 129.55K |
Empower Clinics' MediSure gets Health Canada Medical Device Establishment Licence to source medical devices globally
Empower Clinic Inc's wholly-owned subsidiary Medi+Sure Canada Inc. has obtained a Health Canada Medical Device Establishment License (MDEL) to source class II to class IV diagnostic and therapeutic medical devices from MDALL licensed manufacturers across the world. The integrated healthcare...
Empower Clinics Wholly Owned Subsidiary MediSure Receives Approval of Health Canada Medical Device Establishment Licence (MDEL)
MediSure Canada has obtained a Health Canada Medical Device Establishment License (MDEL # 17716), to Source Class II through Class IV Diagnostic and Therapeutic Medical Devices VANCOUVER, BC / ACCESSWIRE / August 17, 2021 / EMPOWER CLINICS INC. (CBDT:CSE) (8EC:Frankfurt)...
Empower Clinics launches'The Medi-Collective' brand in anticipation of the opening and rollout of its next clinics in September
Empower Clinics Inc has announced the launch of 'The Medi-Collective' (TMC) brand in anticipation of the opening and rollout of the company's next clinics in September. TMC is a multi-disciplinary group of medical practitioners dedicated to applying a collaborative working...
Empower Clinics says it has 13 new clinic locations secured and in various stages of development
Empower Clinics Inc provided an update on its clinic expansion strategy, saying it has 13 pending leases for new locations across Canada. The company currently has four signed leases where construction is underway, including a second flagship location in the...
Empower Clinics Provides Corporate Update On National Clinic Expansion
Strong 2021 Fiscal Performance Supporting Robust Clinic, Testing Expansion and Acquisition Efforts VANCOUVER, BC / ACCESSWIRE / August 11, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, telemedicine...
Empower Clinics achieves major milestone in completing expansion of Kai Medical Laboratory
Empower Clinics Inc announced that it has achieved a major milestone in completing the expansion of its recently acquired Dallas, Texas-based Kai Medical Laboratory, which operates accredited labs that provide reliable and accurate testing solutions for hospitals, clinics, pharmacies, and...
Empower Clinics Completes Landmark Kai Laboratory Expansion
The newly expanded facility substantially enhances KAI LAB's research and service testing capabilities VANCOUVER, BC / ACCESSWIRE / August 4, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers,...
Empower Clinics acquires Canadian diabetes leader Medicare
Empower Clinics Inc has completed the acquisition of Medi+Sure Canada Inc in a move which it said fits seamlessly into its North American e-commerce and distribution strategy. The C$3.5 million cash and stock deal was struck in July with Mario Cortis,...
Empower Clinics Acquires Canadian Diabetes Leader MediSure
Immediate market access expansion to commence in Canada and the US VANCOUVER BC / ACCESSWIRE / July 30, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, telemedicine platforms...
Empower Clinics partners with Save-On-Foods to offer Kai Care COVID-19 test kits in British Columbia
Empower Clinics Inc has announced a pilot program with pharmacy leader Save-On-Foods to sell its Kai Care At Home coronavirus (COVID-19) and influenza A/B saliva test kits in multiple locations across Vancouver, the Lower Mainland and the Okanagan. The integrated healthcare...
Source: https://incomestatements.info
Category: Stock Reports